Drug Shortage Report for MYLAN-MIRTAZAPINE
| Report ID | 232547 |
| Drug Identification Number | 02256096 |
| Brand name | MYLAN-MIRTAZAPINE |
| Common or Proper name | MIRTAZAPINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MIRTAZAPINE |
| Strength(s) | 15MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100BT |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-09-04 |
| Actual start date | 2024-08-20 |
| Estimated end date | 2024-11-26 |
| Actual end date | 2024-11-26 |
| Shortage status | Resolved |
| Updated date | 2024-12-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-07-09 | French | Compare |
| v1 | 2024-07-09 | English | Compare |